{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.110.12.1084","meta":{"versionId":"10","lastUpdated":"2022-03-02T18:05:42.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2022-03-02"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1084","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.110.12.1084"}],"version":"20190315","name":"HibVaccine3DoseScheduleAdministered","title":"Hib Vaccine (3 dose schedule) Administered","status":"active","experimental":false,"date":"2022-03-03T18:46:01-05:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this value set is to represent concepts for a 3-dose haemophilus influenzae type b (Hib) vaccination.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a 3-dose haemophilus influenzae type b (Hib) vaccination.),(Exclusion Criteria: No exclusions.)","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1153"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1156"]}]},"expansion":{"identifier":"urn:uuid:3e1df5de-c5d4-4f9d-8265-c891a1e3f8ee","timestamp":"2023-12-11T02:11:33-05:00","total":8,"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"127787002","display":"Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"170343007","display":"Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"170344001","display":"Administration of second dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"170345000","display":"Administration of third dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"170346004","display":"Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90647","display":"Haemophilus influenzae type b vaccine (Hib), PRP-OMP conjugate, 3 dose schedule, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90697","display":"Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90748","display":"Hepatitis B and Haemophilus influenzae type b vaccine (Hib-HepB), for intramuscular use"}]}}